Triethylamine → 5-Hydroxy-2-(2-tetrahydropyranyl)pyridazin-3(2H)-one

HRID 564044Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 564044
Cl[C:2]1[C:3](=[O:15])[N:4]([CH:9]2[CH2:14][CH2:13][CH2:12][CH2:11][O:10]2)[N:5]=[CH:6][C:7]=1[OH:8].C(N(CC)CC)C>CO.[Pd]>[OH:8][C:7]1[CH:6]=[N:5][N:4]([CH:9]2[CH2:14][CH2:13][CH2:12][CH2:11][O:10]2)[C:3](=[O:15])[CH:2]=1

Komponenten

5

Edukt 2

HCID 8471TriethylamineHCID 547041594-Chloro-5-hydroxy-2-(2-tetrahydropyranyl)pyridazin-3(2H)-one

Produkt 1

HCID 579503555-Hydroxy-2-(2-tetrahydropyranyl)pyridazin-3(2H)-one

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 23938PalladiumKatalysatorHCID 887MethanolLösungsmittel

Versuchsvorschrift

To 14.3 g (62.0 mmol) 4-chloro-5-hydroxy-2-(tetrahydro-pyran-2-yl)-2H-pyridazin-3-one in 200 mL MeOH and 8.71 mL (62.0 mmol) triethylamine is added 5.00 g 10% Pd/C. The reaction mixture is stirred under a hydrogen atmosphere of 1700 hPa at RT for 16 h. The catalyst is removed by filtration and the solvent is evaporated. 200 mL water is added to the residue, the precipitate is collected, washed with water and dried (fraction A, 7.80 g). The aqueous phase is concentrated and the residue is directly added to a reverse HPLC for purification (Waters xbridge; water (0.15% NH4OH)/acetonitril 95:5 to 10:90) to afford fraction B (4.2 g) which is combined with fraction A.

Aufarbeitung

  1. customThe catalyst is removed by filtration
  2. customthe solvent is evaporated
  3. addition200 mL water is added to the residue
  4. customthe precipitate is collected
  5. washwashed with water
  6. customdried (fraction A, 7.80 g)
  7. concentrationThe aqueous phase is concentrated
  8. additionthe residue is directly added to a reverse HPLC for purification (Waters xbridge; water (0.15% NH4OH)/acetonitril 95:5 to 10:90)
  9. customto afford fraction B (4.2 g) which

Quellen und Nachweise

ORD-Eintrag
ord-6d317ded065340298f23bdd2a90c75f2
Quelldatensatz
uspto-grants-2011_11
Patentnummer
US08067590B2

Notizen zur Reaktion

Wird geladen…